Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10490)	6/15/2018 10:58:10 AM
From: donpat	Read Replies (4) \| Respond to of 12873

I, myself, don't really know what NNVC can or can't do. They are a startup with possibilities. I suppose when things clarify or firm up they will let us owners know about it. Right now we are in the dark about Glaxo or anybody else. Good ole Doc Seymour once upon a time told me that big pharmas were interested but only at Phase 2 FDA trials. Those are 2-3 year away. Right now we are at pre FDA trials with Wisconsin's Brandt and SUNY's Moffat. And here we sit. Wondering. Fun, eh?